Cathay Biotech Inc (688065) — Free Cash Flow Generation Index
Cathay Biotech Inc (688065) has a Free Cash Flow Generation Index of 0.69x as of June 2025. Free cash flow of CN¥173.32 Million represents 1% of operating cash flow (CN¥251.82 Million). See 688065 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cathay Biotech Inc Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Cathay Biotech Inc across 7 annual periods. Explore 688065 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Cathay Biotech Inc (2017–2024)
Year-by-year Free Cash Flow Generation Index for Cathay Biotech Inc. For the full company profile including market capitalisation, see market value of Cathay Biotech Inc.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.03x | CN¥-22.38 Million | CN¥820.93 Million | CN¥843.31 Million | ▲ +98.4% |
| 2023 | -1.76x | CN¥-1.00 Billion | CN¥569.45 Million | CN¥1.57 Billion | ▲ +58.4% |
| 2022 | -4.22x | CN¥-3.39 Billion | CN¥803.67 Million | CN¥4.20 Billion | ▼ -185.0% |
| 2021 | -1.48x | CN¥-880.49 Million | CN¥594.18 Million | CN¥1.47 Billion | ▼ -207.5% |
| 2020 | -0.48x | CN¥-248.15 Million | CN¥514.96 Million | CN¥763.11 Million | ▼ -14.4% |
| 2019 | -0.42x | CN¥-151.52 Million | CN¥359.62 Million | CN¥511.14 Million | ▲ +97.6% |
| 2017 | -17.62x | CN¥-941.64 Million | CN¥53.45 Million | CN¥995.09 Million | — |